| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 174441 | Current Opinion in Chemical Engineering | 2015 | 9 Pages |
•Size, charge and surface properties are design considerations for nanoparticles.•Delivery of nanoparticles to primary, metastatic, and multidrug resistant cancers reviewed.•Nanoparticle design must be tailored for diverse cancer physiologies.
Treatment of cancer using nanoparticle-based approaches relies on the rational design of carriers with respect to size, charge, and surface properties. Polymer-based nanomaterials, inorganic materials such as gold, iron oxide, and silica as well as carbon based materials such as carbon nanotubes and graphene are being explored extensively for cancer therapy. The challenges associated with the delivery of these nanoparticles depend greatly on the type of cancer and stage of development. This review highlights design considerations to develop nanoparticle-based approaches for overcoming physiological hurdles in cancer treatment, as well as emerging research in engineering advanced delivery systems for the treatment of primary, metastatic, and multidrug resistant cancers. A growing understanding of cancer biology will continue to foster development of intelligent nanoparticle-based therapeutics that take into account diverse physiological contexts of changing disease states to improve treatment outcomes.
